Clopidogrel effectiveness in patients with ST elevation myocardial infarction

Clopidogrel effectiveness in patients with ST elevation myocardial infarction

Aim. То analyse the effectiveness of clopidogrel therapy (Zilt®) in patients with myocardial infarction (MI), according to genetic variants of Р-450 ЗА cytochromes, platelet adenosine diphosphate (ADPH) receptors, fibrinogen and collagen.Material and methods. The study included 34 patients with ST e...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. V. Sirotkina, E. V. Bogdanova, N. A. Bogan’kova, A. N. Stolyarova, T. V. Mvilova, S. A. Boldueva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2009-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	clopidogrel platelet aggregation genetic polymorphisms platelet receptors cytochrome p-450 3a4 cytochrome p-450 3a5
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1150
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospective Trial on the Pharmacokinetics of Clopidogrel in Hemodialysis Patients
by: Juergen Grafeneder, et al.
Published: (2024-10-01)

Wet granulation method in the technology of 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine tablets, which increases the detoxifying function of the liver
by: A. I. Petrakov, et al.
Published: (2025-06-01)

Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01)

Pharmacokinetic evaluation of the interaction between oral kaempferol and ethanol in rats
by: Zhou Zhaoxiang, et al.
Published: (2016-12-01)

Benzobarbital and fluorbenzobarbital - hepatic monooxygenase system phenobarbital-like inducers
by: T. P. Novozheyeva, et al.
Published: (2011-10-01)

Pharmacological regulation of the activity of cytochrome P450 3A4 AND P450 2C9 isoenzymes by vitamins and natural compounds
by: E. V. Shikh, et al.
Published: (2018-02-01)

Drug-drug interaction between ensitrelvir and tacrolimus in a patient undergoing treatment for COVID-19: a case report
by: Yuki Miyata, et al.
Published: (2025-01-01)

Heterologous Overexpression of Cytochrome P450BM3 from <i>Bacillus megaterium</i> and Its Role in Gossypol Reduction
by: Wenpeng Fan, et al.
Published: (2025-05-01)

METABOLIC ACTIVITY STUDY IN PEOPLE WITH DRUG ALLERGY USING «COCKTAIL» PHENOTYPING METHOD
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Toxic Effects of p-Chloroaniline on Cells of Fungus <i>Isaria fumosorosea</i> SP535 and the Role of Cytochrome P450
by: Shicong Huang, et al.
Published: (2025-06-01)

THE DEPENDENCE OF TRANSLOCATOR PROTEIN TSPO LEVEL AND CYTOCHROME P450SCC FROM HISTOTYPE OF TUMOR IN PATIENTS WITH RENAL CELL CARCINOMA
by: R. A. Zukov, et al.
Published: (2016-02-01)

Nephro- and Cardiotoxic Effects of Etoricoxib: Insights into Arachidonic Acid Metabolism and Beta-Adrenergic Receptor Expression in Experimental Mice
by: Yahya F. Jamous, et al.
Published: (2024-10-01)

Characterisation of the Self‐Sufficient Cytochrome P450 CYP116B234 From Rhodococcus globerulus and Its Suggested Native Role in 2‐Hydroxyphenylacetic Acid Metabolism
by: Simran Kundral, et al.
Published: (2025-03-01)

The risk of milk thistle (<i>Silybum marianum</i>) drug interactions
by: A. S. Kazakov, et al.
Published: (2018-02-01)

A potentially lethal interaction: Migraine, human immunodeficiency virus and ergotism – A primary care case report
by: Ahmad Sahli Mahzuz Ismail, et al.
Published: (2025-02-01)

Discovery of strigol synthase from cotton (Gossypium hirsutum): The enzyme behind the first identified germination stimulant for Striga
by: Takatoshi Wakabayashi, et al.
Published: (2025-03-01)

Computational journey to unveil organophosphorothioate pesticides’ metabolism: A focus on chlorpyrifos and CYP2C19 mutational landscape
by: Lorenzo Pedroni, et al.
Published: (2024-12-01)

Clinical Significance of Cytochrome P4502C19 (681G/A) Gene Polymorphism in Residents of the Trans-Baikal Territory in Treatment of Acid-Dependent Diseases
by: A. A. Zhilina, et al.
Published: (2022-03-01)

Study on Phenotypical Activity of Isoenzyme CYP3A4 in Children
by: B. I. Kantemirova, et al.
Published: (2020-05-01)

Determination of the activity of drug-metabolizing enzymes - the prospects for their use in clinical practice
by: V. V. Smirnov, et al.
Published: (2018-02-01)

The Cytochrome CYP4 in Breast and Other Cancers
by: Gloria M. Calaf, et al.
Published: (2025-07-01)

How Plant Polyhydroxy Flavonoids Can Hinder the Metabolism of Cytochrome 3A4
by: Carina S. P. Vieira, et al.
Published: (2025-03-01)

Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes
by: D. V. Ivashchenko, et al.
Published: (2020-04-01)

Activities of cytochrome P450 enzyme CYP102A16 from Bacillus sp. C3
by: LI Ze-li, et al.
Published: (2012-11-01)

A pilot study on cytochrome p450 2B6 single nucleotide polymorphism among Fulani ethnic group of Northwest Nigeria.
by: Umar, M.T.*1, Abubakar, M.B. 2, Chika, A. 1, Gada, Y.A. 1
Published: (2024-01-01)

Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone
by: Millicent G. A. Bennett, et al.
Published: (2025-02-01)

Molecular Mechanisms Contributing to the Impairment of Steroid Hormones, Sperm Characteristics, and Testicular Architecture in Male Rabbits After Chronic Exposure to Cadmium: Role of Gallic Acid and Selenium as Antioxidants
by: Salah A. Sheweita, et al.
Published: (2025-04-01)

Biosynthesis of tyrosine-derived i-melanin and its characteristics for organic thin film transistor device
by: Yoonjae Kim, et al.
Published: (2025-06-01)

«COCKTAIL» METHODS OF CYTOCHROME P450 ISOFORMS ACTIVITY DETERMINATION <i>IN VIVO</i> USING BIOANALYTICAL METHODS: ACTUAL METHODS REVIEW AND OPPORTUNITIES OF THEIR APPLICATION IN CLINICAL PRACTICE
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Evaluation of Southern African wild edible plants for potential herb-drug interactions through ex vivo p-glycoprotein and in vitro cytochrome P450 3A4 inhibitory effects
by: P.S. Kheoane, et al.
Published: (2025-02-01)

Global transcriptome modulation by xenobiotics: the role of alternative splicing in adaptive responses to chemical exposures
by: Andrew J. Annalora, et al.
Published: (2024-11-01)

Association Between the Expression of Cytochrome P450 and Glutathione S-transferase Enzyme and Antrochoanal Polyp Pathogenesis
by: Mehmet Gökhan Demir, et al.
Published: (2025-04-01)

Genome-wide identification and transcriptome analysis of the cytochrome P450 genes revealed its potential role in the growth of Flammulina filiformis
by: Xun Liu, et al.
Published: (2025-04-01)

Dose-dependent modulation of hepatic cytochrome P450 enzymes by tenvermectin: implications for medication safety and combination therapy
by: Jianping Liang, et al.
Published: (2025-08-01)

Analysis of CYP701A1 genes in gossypium species and functional characterization through gene silencing
by: Zhao Liang, et al.
Published: (2025-02-01)

In vitro assays identified thiohydantoins with anti-trypanosomatid activity and molecular modelling studies indicated possible selective CYP51 inhibition
by: Priscila Goes Camargo, et al.
Published: (2025-01-01)

Bacterial Cytochrome P450 Involvement in the Biodegradation of Fluorinated Pyrethroids
by: Mohd Faheem Khan, et al.
Published: (2025-04-01)

UvCYP503 is required for stress response and pathogenicity in Ustilaginoidea virens
by: Xiuxiu Cao, et al.
Published: (2025-12-01)

Comparative study of cytochrome P450 expression in the kidneys of Lepus yarkandensis and Oryctolagus cuniculus
by: Jianping Zhang, et al.
Published: (2025-02-01)

Expression and Purification of the Full Length and N-Terminal Truncated Variants of Insect CYP6Z2 in the Cytosol of Escherichia Coli for Potential 3D Experimental Studies
by: Michael Olugbenga Kusimo, et al.
Published: (2024-10-01)